Provided herein are methods for treating and/or preventing a cancer or a tumor syndrome in a patient comprising administering an effective amount of a TOR kinase inhibitor to a patient having cancer or a tumor syndrome characterized by a LKB 1 and/or AMPK gene or protein loss or mutation.